- Presentations
- 6
- Markets
- 1
Keppra is a brand of Levetiracetam marketed by UCB, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Levetiracetam
- Brand owner
- UCB
- Registered in
- United States
- Strengths and forms
- 500 mg/5 mL injection, 100 mg/mL oral solution, 1000 mg tablet, 250 mg tablet, 500 mg tablet, 750 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Keppra 500 mg/5 mL injectionIntravenous | UCB | US FDA | Available on request |
| Keppra 100 mg/mL oral solutionOral | UCB | US FDA | Available on request |
| Keppra 1000 mg tabletOral | UCB | US FDA | Available on request |
| Keppra 250 mg tabletOral | UCB | US FDA | Available on request |
| Keppra 500 mg tabletOral | UCB | US FDA | Available on request |
| Keppra 750 mg tabletOral | UCB | US FDA | Available on request |
Equivalent brands
Other brands of Levetiracetam.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Keppra
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.